NCT03326206

Brief Summary

Since 2009, a programmatic community-based strategy (COPE) has been implemented to address health disparities among Navajo individuals living with multiple chronic conditions. COPE (Community Outreach and Patient Empowerment) targets individual, family, and health system-level factors through four activities: 1) coordination between community health representatives (CHRs) and Indian Health Service providers; 2) CHR competency with standardized training; 3) a culturally-sensitive health promotion curriculum for patients and families; and 4) strong CHR supervision. COPE has been implemented throughout Navajo Nation. Enrollment is programmatic; in other words, the decision to enroll a patient in COPE occurs independently of whether the patient is in this study. Participants receive the COPE intervention in the same manner and intensity, whether they are included in this observational study or not. The main goal of this observational research is to understand if COPE improves the lives of participating community members. The Primary Aim is to assess the impact of the COPE Project on changes in HbA1c and other CVD risk factors. Hypothesis: Patients enrolled in the COPE program will experience a reduction in HbA1c compared to the control group. Secondary aims are: 1) To understand if COPE improves patients' own self-reported outcomes. Hypothesis: COPE patients will report better health compared with their own baseline at 12 months. 2) To Identify factors associated with increased effectiveness of the COPE Project at the individual, community, and health system level using a mixed-model approach. 3) To understand diverse stakeholder perspectives on COPE impact and value among CHRs, providers and the health care system. Hypothesis: Compared with baseline, CHRs will report greater empowerment in their work, providers will report greater confidence in CHRs. The observational cohort will be comprised of individuals with diabetes receiving care at one of the participating health facilities. Cases include individuals participating in the COPE intervention; controls are non-COPE participants identified within the same hospital and matched based on similar baseline characteristics. Study findings will improve clinical and patient-decision making and the health of marginalized AI/ANs by informing policies to promote CHR interventions in rural and underserved communities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28,813

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Typical duration for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2015

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 24, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 31, 2017

Completed
8.1 years until next milestone

Results Posted

Study results publicly available

December 16, 2025

Completed
Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

2.2 years

First QC Date

October 24, 2017

Results QC Date

November 20, 2017

Last Update Submit

May 2, 2026

Conditions

Keywords

NavajoCommunity Health WorkersCommunity Health RepresentativesTribal health systemsAmerican IndianRuralHealth disparities

Outcome Measures

Primary Outcomes (1)

  • Change in Percentage of Glycated Hemoglobin (HbA1c)

    Change in Hemoglobin A1c measured at 24 months, compared with baseline

    24 months

Secondary Outcomes (13)

  • Change in Systolic Blood Pressure

    24 months

  • Change in Low-density Lipoprotein

    24 months

  • Change in Body Mass Index

    24 months

  • Change in Primary Outpatient Services

    24 months

  • Change in Specialty Outpatient Services

    24 months

  • +8 more secondary outcomes

Other Outcomes (3)

  • Patient-reported Good Health

    12 months

  • Patient-reported Sense of Control

    12 months

  • Patient-reported Ability to Cope

    12 months

Study Arms (2)

COPE participants

Individuals living with diabetes seen at a study site who were enrolled in the COPE programmatic intervention during the study period. Participation in COPE consists of receiving home visits by a Navajo Community Health Representative (CHR) once or twice a month for a period of at least 12 months. CHRs use structured patient coaching materials to support behavior change. CHRs also check vital signs, monitor blood glucose levels through finger sticks, and facilitate access to appointments and medical refills. CHRs communicate regularly with providers through electronic health record documentation and case management rounds. In-person or telephone communication is be used to address acute issues that may arise.

Non-COPE participants

Individuals living with diabetes seen at a study site, did not participate in the COPE programmatic intervention, and had comparable baseline characteristics.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals receiving care at a Navajo Area Indian Health Service facility, living with diabetes

You may qualify if:

  • Diagnosis of diabetes
  • Treated at a participating IHS facility corresponding to their home residence

You may not qualify if:

  • Not seen in one of the six participating clinical sites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Chinle Comprehensive Health Care Facility

Chinle, Arizona, 86503, United States

Location

Tsehootsooi Medical Center

Fort Defiance, Arizona, 86504, United States

Location

Kayenta Health Center

Kayenta, Arizona, 86033, United States

Location

Crownpoint Health Center Facility

Crownpoint, New Mexico, 87313, United States

Location

Gallup Indian Medical Center

Gallup, New Mexico, 87301, United States

Location

Northern Navajo Medical Center

Shiprock, New Mexico, 87420, United States

Location

Related Publications (4)

  • Franz C, Atwood S, Orav EJ, Curley C, Brown C, Trevisi L, Nelson AK, Begay MG, Shin S. Community-based outreach associated with increased health utilization among Navajo individuals living with diabetes: a matched cohort study. BMC Health Serv Res. 2020 May 25;20(1):460. doi: 10.1186/s12913-020-05231-4.

  • Brown C, Lalla A, Curley C, King C, Muskett O, Salt S, Ray K, Begay MG, Nelson AK, Shin S. Community-clinic linkages: qualitative provider perspectives on partnering with community health representatives in Navajo Nation. BMJ Open. 2020 Feb 12;10(2):e031794. doi: 10.1136/bmjopen-2019-031794.

  • Lalla A, Salt S, Schrier E, Brown C, Curley C, Muskett O, Begay MG, Shirley L, Clark C, Singer J, Shin S, Nelson AK. Qualitative evaluation of a community health representative program on patient experiences in Navajo Nation. BMC Health Serv Res. 2020 Jan 8;20(1):24. doi: 10.1186/s12913-019-4839-x.

  • Trevisi L, Orav JE, Atwood S, Brown C, Curley C, King C, Muskett O, Sehn H, Nelson KA, Begay MG, Shin SS. Integrating community health representatives with health care systems: clinical outcomes among individuals with diabetes in Navajo Nation. Int J Equity Health. 2019 Nov 27;18(1):183. doi: 10.1186/s12939-019-1097-9.

MeSH Terms

Conditions

Diabetes MellitusMetabolic SyndromeHypertensionChronic Disease

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesInsulin ResistanceHyperinsulinismVascular DiseasesCardiovascular DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Limitations and Caveats

This is an observational study using routine clinical data for endpoints other than patient-reported outcomes. Therefore, the participant flow and adverse event reporting did not conform to clinical trial protocols. For patient-reported outcomes, we used mixed methods (including pre-post surveys among a sub-set of COPE participants and qualitative interviews) but did not collect or compare data from a control arm.

Results Point of Contact

Title
Dr. Sonya Shin
Organization
Brigham and Women's Hospital

Study Officials

  • Sonya S Shin, MD MPH

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Physician

Study Record Dates

First Submitted

October 24, 2017

First Posted

October 31, 2017

Study Start

November 1, 2013

Primary Completion

December 31, 2015

Study Completion

December 31, 2015

Last Updated

May 27, 2026

Results First Posted

December 16, 2025

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations